Skip to content
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
TNC FlipBook Classic items
2022-11-03_PR_Cova_Results_EN
By
admin
November 1, 2025
2023_01_19_PR_NEGMA_EN
By
admin
November 1, 2025
2023-01-19_CP_NEGMA_FR
By
admin
November 1, 2025
2023-01-05_Biophytis_PR_conference_JP_MORGAN_EN
By
admin
November 1, 2025
2023-02-02_PR_Final_Results_COVA
By
admin
November 1, 2025
2023-02-02_CP_Resultats_finaux_COVA
By
admin
November 1, 2025
2023-01-31_PR_2023_H1_2022_and_Restated_2021_EN
By
admin
November 1, 2025
2023-01-01_CP_Comptes_S1_20222_Retraite_2021_FR
By
admin
November 1, 2025
2023-03-01_CP_Exploit_Pharm
By
admin
November 1, 2025
2024_03_27_CP_Acces_Precoce_France_FR
By
admin
November 1, 2025
←
1
2
3
4
5
6
7
8
9
…
10
11
12
13
14
…
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
→
Go to Top
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
